Data topics

Winning favorable formulary access is only the first step in a successful payer strategy. The real challenge is determining whether a contract will generate profitable prescription growth—and proving that improved access translates into measurable pull-through. This guide explains how payer contract analytics enables market access, finance, and commercial teams to model the financial impact of formulary agreements before they're signed and continuously measure performance after launch. Learn how leading organizations combine formulary intelligence, claims, hub services, specialty pharmacy data, and field execution metrics to evaluate rebate effectiveness, forecast contract ROI, monitor payer performance, and identify opportunities to improve pull-through.

When pharma brands strike major deals, they don’t just gain access—they inherit complex tradeoffs. From navigating volume vs. margin to managing payer fatigue, these tradeoffs shape strategy long after contracts are signed. This blog breaks down five recurring tensions in market access and shows how AI-powered analytics helps commercial and HEOR teams model scenarios, simulate outcomes, and move from rigid strategy to adaptive execution.

With the FDA’s landmark approval of CAR-T therapies like Abecma and Carvykti as earlier-line treatments, the commercial landscape is shifting rapidly. This blog explores the next phase of CAR-T market access and the analytics brand teams need to navigate it. Learn how to forecast pull-through, identify high-opportunity accounts, and guide sales execution using real-world data, segmentation strategies, and AI-powered insights. From payer dynamics to provider referral patterns, find out what it takes to win in a competitive, high-cost therapeutic space.